Alpha-lipoic acid - the special antioxidant

Hyperglycemia, which often occurs in diabetes mellitus patients, causes increased production of free oxygen radicals that damage peripheral nerves.

Alpha-lipoic acid is a free-radical scavenger that catches damaging oxygen radicals both in aqueous and lipid soluble cell environments, thereby counteracting the sensory disorders of diabetic polyneuropathy.

Since our body can only absorb a very small quantity of alpha-lipoic acid through our diet like innards, an additional supply is recommended.

Thiogamma® contains the active ingredient alpha-lipoic acid that protects the nerve cell from damaging degradation products and free radicals, thus being able to improve nerve conductivity.

  • Therapeutic Indications
    Dysaesthesia in diabetic polyneuropathy.
  • Active Substance and Composition
    One capsule contains alpha-lipoic acid 600 mg. Excipients: Sorbitol and Ponceau 4R.

    Alpha lipoic acid

    For further substances read the Patient information leaflet.
  • Dosage and Method of Application
    In dysaesthesia in diabetic polyneuropathy the recommended daily dosage for adults is soft capsule Thiogamma® 600 oral (equals 600 mg alpha-lipoic acid), that should be taken in doses approximately 30 minutes before the first meal of the day. In sever dysaesthesia, an initial treatment using alpha-lipoic acid infusions may be suitable.

    Thiogamma® 600 oral capsules should be taken whole with sufficient fluid on an empty stomach. The simultaneous consumption of food may hinder resorption. It is therefore particularly important in patients with a prolonged stomach emptying time that the tablets are taken half an hour before breakfast.

    As diabetic polyneuropathy is a chronic disease, long-term therapy may be required.
  • Package Sizes
    • 30 Soft Capsules - PZN 04972007
    • 60 Soft Capsules - PZN 04972013
    • 100 Soft Capsules - PZN 04774626
  • Obligatory Text
    Thiogamma® 600 oral. Active substance: Alpha-lipoic acid 600 mg. Therapeutic indications: Dysaesthesia in diabetic polyneuropathy. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. WÖRWAG Pharma GmbH & Co. KG, 71034 Böblingen
  • Downloads

Related Products